Veritas Pharma, Inc. (OTC Pink: VRTHF) (CSE: VRT) Surges 56% After Preparing for Human Trials for CTL-X for Pain Management

Veritas Pharma, Inc. (OTC Pink: VRTHF) (CSE: VRT) operates as an emerging pharmaceutical company utilizing medical marijuana. The company aims to develop efficient cannabis treatments from pain, nausea, PTSD, anxiety, epilepsy, and more. Shares of the medical marijuana company are surging 56.48%, through afternoon trading on Thursday, November 8, 2018. Over the past month, Veritas Pharma has seen average daily…

Read More